Soluble Ferric Pyrophosphate

Rockwell Medical

Rockwell Medical Announces Iron Delivery Drug SFP Meets Goals

Wixom-based Rockwell Medical Monday announced successful results from a clinical study of Soluble Ferric Pyrophosphate, its investigational iron-delivery drug now in Phase 3 clinical studies for the treatment of iron deficiency in hemodialysis patients.

WWJ Newsradio 950–02/04/2013